| Description |
The ability to predict a drug response will have a substantial impact on the pharmaceutical industry. Pharmaceutical companies will be affected from top to bottom. Among the many benefits of pharmacogenomics will be reduced incidence of adverse drug events, improved clinical outcomes, and reduced costs. In order to ensure that you are not left behind in this highly competitive field, we have assembled leaders in the fields of genomics and pharmaceutical development to share their experiences. At our event, you will learn how to:
Increase your drug’s speed to market
Dramatically reduce the number of adverse drug reactions
Discover potential therapies
Create more effective and less expensive vaccines
Decrease the number of failed clinical trials
Fight disease before the first symptom occurs
Specifically, you will learn about:
Structural genomics in drug discovery
Applications of Genomics-Based technologies to support the utilization of SNPs for the acceleration of drug discovery and development
Using genetics to identify and validate drug targets
Predicting response to anti-metabolite therapy in common cancers
Determine the size of your pharmacogenomic R&D budget by identifying drug leads with the highest ROI
Using haplotypes in drug discovery & development
Using SNPs in target discovery
Medical impact of genetic diversity: Identifying the opportunities
Applications of SNP genotyping in drug development
Gene therapy as a reality today
Delivery methods: What’s on the horizon?
And more!
|
|
